Developing a Patient-Directed Policy Framework for Managing Orphan and Ultra-Orphan Drugs Throughout Their Lifecycle

INTRODUCTION: Policy decisions related to orphan and ultra-orphan drugs challenge traditional decision-making processes and often frustrate those affected by them. In general, these drugs are associated with significant uncertainties around clinical benefit, ‘value for money’, affordability, and ‘ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Menon, Devidas, Stafinski, Tania, Dunn, Andrea, Wong-Rieger, Durhane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315524/
https://www.ncbi.nlm.nih.gov/pubmed/25559762
http://dx.doi.org/10.1007/s40271-014-0108-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315524/
https://www.ncbi.nlm.nih.gov/pubmed/25559762
http://dx.doi.org/10.1007/s40271-014-0108-6

Ejemplares similares